Introduction: Henan Xintiandi Pharmaceutical Co., Ltd. is a private joint-stock company invested by corporate shareholders, with a registered capital of 99 million yuan and total assets of 230 million yuan. The company was established in September 2005, with a total area of 654.38+0.4 million square meters and employees of 654.38+0.000. Specializing in research and development, production and sales of pharmaceutical intermediates and fine chemical products. The company's leading products, L-P-hydroxyphenylglycine and L-P-hydroxyphenylglycine Dunn potassium salt, were recognized as high-tech products by the Science and Technology Department of Henan Province, and the L-P-hydroxyphenylglycine and L-P-hydroxyphenylglycine Dunn potassium salt projects were listed as the first and second batch of high-tech industrialization key projects by the Henan Provincial Government. Our company is the earliest manufacturer in China to develop and produce L- p-hydroxyphenylglycine and its derivatives, and its technical and quality indicators have reached the level of similar products in the world. The company is a state-level high-tech enterprise, a key enterprise of the Ministry of Commerce, and a key export enterprise of high-tech products in Henan Province. In 2006 and 2007, the company successively obtained ISO900 1:2000 quality management system, BSEN ISO14001:2004 environmental management system, OHSAS18001:/issued by Moody's International Certification Co., Ltd.
Legal Representative: Xie Jianzhong.
Date of establishment: September 2005-15
Registered capital: 99 million yuan.
Industrial and commercial registration number: 411082100006960.
Type of enterprise: other joint stock limited companies (unlisted)
Company Address: East of South Section of Wei Wu Road, changge city